Methods for diagnosing and treating bicuspid aortic valve and/or aortopathies
US-2016109458-A1 · Apr 21, 2016 · US
US11393137B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11393137-B2 |
| Application number | US-201716345165-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 31, 2017 |
| Priority date | Oct 31, 2016 |
| Publication date | Jul 19, 2022 |
| Grant date | Jul 19, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention describes a new functional biomarker of vascular inflammation and its use in predicting all-cause or cardiac mortality. The invention also provides a method for stratifying patients according to their risk of all-cause or cardiac mortality using data gathered from a computer tomography scans of a blood vessel to determine a specific combination of structural and functional biomarkers of vascular inflammation and disease.
Opening claim text (preview).
The invention claimed is: 1. A method of predicting a mortality risk or risk of a patient suffering a cardiovascular event, said method comprising: (a) using data gathered from a computer tomography (CT) scan along a length of a blood vessel to determine: (i) calcium index (Calcium-i); and/or (ii) fibrous plaque index (FPi); and at least one of (iii) fat attenuation index of perivascular adipose tissue (FAI PVAT ); and/or (iv) perivascular water index (PVWi); and (b) comparing each of the values determined in (a) to a pre-determined cut-off value or using the absolute value of each variable determined in (a) in order to generate an output value that indicates the patient's mortality risk or risk of suffering a cardiovascular event. 2. The method according to claim 1 , wherein both FAI PVAT and PVWi are determined in step (a). 3. The method according to claim 1 , wherein the data is gathered from a computer tomography scan along a length of the right coronary artery, left anterior descending artery, left circumflex artery, aorta, carotid arteries or femoral arteries. 4. The method according to claim 3 wherein the data is gathered from a computer tomography scan along a 4 cm length, starting 1 cm distally to the origin of the right coronary artery. 5. The method according to claim 1 , wherein step (a) further comprises using the data gathered from a computer tomography scan along a length of a blood vessel to determine (v) fat attenuation index of epicardial adipose tissue (FAI EpAT ) and (vii) volumetric perivascular characterization index (VPCI), and wherein the value of (v) is included in step (b) of claim 1 . 6. The method according to claim 1 , wherein step (a) further comprises using the data (lathered from a computer tomography scan along a length of a blood vessel to determine (vi) epicardial adipose tissue volume (EpAT-vol), wherein the value of (vi) is included in step (b) of claim 1 . 7. The method according to claim 1 , further comprising determining one or more of (viii) age and (ix) gender of the patient and wherein the value of (viii) and/or (ix) is included in step (b) of claim 1 . 8. The method according to claim 1 , wherein coefficients for each of (i) to (iv) are derived from Cox hazard or logistic regression models. 9. The method according to claim 1 , wherein the cut-off points for each of (i) to (iv) are derived from receiver operating characteristic (ROC) curves. 10. The method according to claim 1 , wherein the output value is a continuous single valued function or a value that falls within one of three discrete brackets corresponding to low, medium and high risk of a cardiac event, cardiac death or all-cause mortality. 11. The method according to claim 1 , wherein the method is used to stratify patients according to their risk of all-cause or cardiac mortality. 12. The method according to claim 1 , wherein the patient has been diagnosed with vascular inflammation, or a condition known to be associated with vascular inflammation. 13. The method according to claim 1 , wherein the method is used to non-invasively monitor aortic aneurysms and/or carotid plaques, wherein said method does not include determining epicardial adipose tissue volume (EpAT-vol) or fat attenuation index of epicardial adipose tissue (FAI EpAT ). 14. The method according to claim 1 , wherein step (a) further comprises using the data gathered from a computer tomography scan along a length of a blood vessel to determine (v) fat attenuation index of the epicardial adipose tissue (FAI EpAT ) and wherein the value of (v) is included in step (b) of claim 1 .
Related publications grouped by family.
Answers are generated from the same data shown on this page.